Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Qilu Pharmaceutical Co., Ltd.
China Medical University, China
Uganda Cancer Institute
Qilu Pharmaceutical Co., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Shanghai Pulmonary Hospital, Shanghai, China
Jiangsu Hansoh Pharmaceutical Co., Ltd.
China Medical University, China
Women's Hospital School Of Medicine Zhejiang University
Shanghai Pulmonary Hospital, Shanghai, China
Obstetrics & Gynecology Hospital of Fudan University
Peking Union Medical College Hospital